ViroGates A/S (CPH:VIRO)

Denmark flag Denmark · Delayed Price · Currency is DKK
12.75
-0.20 (-1.54%)
Oct 24, 2025, 2:11 PM CET
-1.54%
Market Cap98.61M
Revenue (ttm)9.40M
Net Income (ttm)-12.69M
Shares Out7.73M
EPS (ttm)-1.64
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,508
Average Volume7,457
Open12.75
Previous Close12.95
Day's Range12.75 - 12.75
52-Week Range5.98 - 31.00
Beta1.06
RSI65.62
Earnings DateNov 6, 2025

About ViroGates

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company’s product includes suPARnostic TurbiLatex, a latex particle-enhan... [Read more]

Sector Healthcare
Founded 2000
Employees 10
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol VIRO
Full Company Profile

Financial Performance

In 2024, ViroGates's revenue was 7.14 million, an increase of 2.22% compared to the previous year's 6.99 million. Losses were -14.35 million, 18.6% more than in 2023.

Financial Statements

News

There is no news available yet.